PRECLINICAL ISOLATED ORGAN PERFUSION SYSTEM MARKET ANALYSIS

Isolated organ perfusion involves maintaining an organ in viable status, either by single pass or recirculation with the medium. Isolated organ perfusion has been documented in distribution studies involving several organs including lung, kidney and brain. These isolated organ perfusion techniques allow higher concentrations of chemotherapy to be delivered to the targeted organ while ensuring the vitality of other organs. Increasing organ transplantation across the globe is expected to boost the market growth. For instance, according to an article titled Consortium on Organ Preservation in Europe (COPE) published by the CORDIS European Commission in December 2018, the prevalence of end-stage chronic kidney disease is around 4.1-8% in the over 18-age group in the U.K.

The global preclinical isolated organ perfusion system market is estimated to be valued at US$ 442.8 million in 2020 and is expected to exhibit a CAGR of 4.2% during the forecast period (2020-2027).

Figure 1. Global Preclinical Isolated Organ Perfusion System Market Share (%), by Region, 2020

To learn more about this report, request a free sample copy

Rising cases of cardiovascular diseases worldwide are expected to propel growth of the global preclinical isolated organ perfusion system market.

Rising incidence of cardiovascular worldwide is expected to drive the market growth during the forecast period. For instance, according to an article published by the World Health Organization, 2018, 15 million people suffer stroke worldwide each year. Out of these, 5 million die and another 5 million are permanently disabled.

Figure 2. Global Preclinical Isolated Organ Perfusion System Market Share (%), by Type, 2020

To learn more about this report, request a free sample copy

The increasing incidence of cardiovascular diseases in North America is expected to drive the market growth.

North America is expected to hold dominant position in the global preclinical isolated organ perfusion system market owing to increasing prevalence of cardiovascular diseases in the region. For instance, according to an article published by the Centers for Disease Control and Prevention Report, in 2020, around 18.2 million adults over 30 years of age suffered from coronary artery disease in the U.S.

Global Preclinical Isolated Organ Perfusion System Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) pandemic and resulting lockdowns in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare is one such sector which has been impacted significantly by the COVID-19 pandemic.

Lockdowns in various countries have placed an economic burden on the healthcare sector. Moreover, the coronavirus pandemic has hampered the development, production, and supply of drugs and other healthcare products, and affected growth of healthcare businesses of various companies across the globe.

As a result, the impact of the COVID-19 pandemic is expected to limit growth of the global preclinical isolated organ perfusion system market during the forecast period.

Key Players

Major players operating in the global preclinical isolated organ perfusion system market are World Precision Instruments Inc., Radnoti LLC, MDE GmbH, Harvard Bioscience Inc., emka TECHNOLOGIES S.A.S., Danish Myo Technology AS, ADInstruments Pty Ltd. and Experimetria Ltd. among others.